within Pharmacolibrary.Drugs.ATC.L;

model L02BA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 11.4 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Fulvestrant is a selective estrogen receptor degrader (SERD) used primarily in the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. It binds to estrogen receptors and accelerates their degradation, thereby inhibiting estrogen signaling. Fulvestrant is approved and used in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult female breast cancer patients. Model parameters are based on studies of repeated IM injection with clinical standard dosage.</p><h4>References</h4><ol><li><p>Robertson, JF, &amp; Harrison, M (2004). Fulvestrant: pharmacokinetics and pharmacology. <i>British journal of cancer</i> 90 Suppl 1(Suppl 1) S7–S10. DOI:<a href=&quot;https://doi.org/10.1038/sj.bjc.6601630&quot;>10.1038/sj.bjc.6601630</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15094758/&quot;>https://pubmed.ncbi.nlm.nih.gov/15094758</a></p></li><li><p>Downton, T, et al., &amp; Lim, E (2022). Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status. <i>Drug design, development and therapy</i> 16 2933–2948. DOI:<a href=&quot;https://doi.org/10.2147/DDDT.S380925&quot;>10.2147/DDDT.S380925</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36081610/&quot;>https://pubmed.ncbi.nlm.nih.gov/36081610</a></p></li><li><p>Curran, M, &amp; Wiseman, L (2001). Fulvestrant. <i>Drugs</i> 61(6) 807–814. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200161060-00013&quot;>10.2165/00003495-200161060-00013</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11398912/&quot;>https://pubmed.ncbi.nlm.nih.gov/11398912</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L02BA03;
